These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 26465835)

  • 1. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical sparing pattern of left ventricular myocardial
    Van Der Gucht A; Cottereau AS; Abulizi M; Guellich A; Blanc-Durand P; Israel JM; Galat A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Dec; 25(6):2072-2079. PubMed ID: 28447284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
    J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of myocardial
    Pradel S; Brun S; Victor G; Pascal P; Fournier P; Ribes D; Lavie-Badie Y; Galinier M; Carrié D; Berry I; Lairez O;
    J Nucl Cardiol; 2020 Feb; 27(1):96-105. PubMed ID: 29881913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
    Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.
    Cappelli F; Gallini C; Costanzo EN; Tutino F; Ciaccio A; Vaggelli L; Bartolini S; Morini S; Martone R; Angelotti P; Frusconi S; Di Mario C; Perfetto F
    Int J Cardiol; 2018 Mar; 254():346-350. PubMed ID: 29407121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracardiac soft tissue uptake, evidenced on early
    Malka N; Abulizi M; Kharoubi M; Oghina S; Galat A; Le Bras F; Moktefi A; Guendouz S; Molinier-Frenkel V; Fanen P; Funalot B; Lefaucheur JP; Blanc-Durand P; Deux JF; Audard V; Bodez D; Itti E; Damy T
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2396-2406. PubMed ID: 32157431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.
    Gallini C; Tutino F; Martone R; Ciaccio A; Costanzo EN; Taborchi G; Morini S; Bartolini S; Farsetti S; Di Mario C; Perfetto F; Cappelli F
    J Nucl Cardiol; 2021 Feb; 28(1):90-99. PubMed ID: 30767162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis.
    Galat A; Van Der Gucht A; Colombat M; Attias D; Itti E; Meignan M; Lebras F; Molinier-Frenkel V; Benhaiem N; Guellich A; Rosso J; Damy T
    J Nucl Cardiol; 2015 Aug; 22(4):853-7. PubMed ID: 26002815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.
    Monfort A; Rivas A; Banydeen R; Inamo J; Farid K; Neviere R
    Respir Res; 2022 Mar; 23(1):72. PubMed ID: 35346209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
    Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of
    Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
    Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.